Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

D E Orange, M Jegathesan, N E Blachère, M O Frank, H I Scher, M L Albert, R B Darnell

Open source

DOI
10.1038/sj.pcan.4500694
Published
2004-03-01
Container
Prostate Cancer and Prostatic Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/sj.pcan.4500694,
  title = {Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy},
  author = {D E Orange and M Jegathesan and N E Blachère and M O Frank and H I Scher and M L Albert and R B Darnell},
  year = {2004},
  journal = {Prostate Cancer and Prostatic Diseases},
  doi = {10.1038/sj.pcan.4500694},
  url = {https://doi.org/10.1038/sj.pcan.4500694}
}

RIS

TY  - JOUR
TI  - Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy
AU  - D E Orange
AU  - M Jegathesan
AU  - N E Blachère
AU  - M O Frank
AU  - H I Scher
AU  - M L Albert
AU  - R B Darnell
PY  - 2004
JO  - Prostate Cancer and Prostatic Diseases
DO  - 10.1038/sj.pcan.4500694
UR  - https://doi.org/10.1038/sj.pcan.4500694
ER  - 

APA

Orange, D. E., Jegathesan, M., Blachère, N. E., Frank, M. O., Scher, H. I., Albert, M. L., & Darnell, R. B. (2004). Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/sj.pcan.4500694

Source records